NRC Health (NRC) Financials
NRC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 136.2 million | 129.6 million |
| March 31, 2026 | 134.6 million | 121.1 million |
| Dec. 31, 2025 | 134.9 million | 120.9 million |
| Sept. 30, 2025 | 135.7 million | 121.4 million |
NRC Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 62000 | ? |
| March 31, 2026 | 5.3 million | 1.6 million |
| Dec. 31, 2025 | 6.1 million | 1.9 million |
| Sept. 30, 2025 | 10.2 million | 925000 |
NRC Net Income
| Date | Net Income |
|---|---|
| June 30, 2026 | -3.3 million |
| March 31, 2026 | 3.2 million |
| Dec. 31, 2025 | 1.8 million |
| Sept. 30, 2025 | 4.1 million |
NRC Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 3.3 million | 86.0 million | - |
| March 31, 2026 | 2.5 million | 74.0 million | - |
| Dec. 31, 2025 | 4.1 million | 75.0 million | - |
| Sept. 30, 2025 | 2.2 million | 76.0 million | - |
NRC Shares Outstanding
NRC Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 1.3 million | - | 22.9 million | - |
| March 31, 2026 | 1.8 million | - | 13.4 million | - |
| Dec. 31, 2025 | 1.1 million | - | 14.4 million | - |
| Sept. 30, 2025 | 3.6 million | - | 12.3 million | - |
NRC Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 35.4 million | - |
| March 31, 2026 | 34.8 million | 15.8 million |
| Dec. 31, 2025 | 35.2 million | 16.1 million |
| Sept. 30, 2025 | 34.6 million | 14.6 million |
NRC
Price: $21.12
Dividend Yield: 2.82%
Forward Dividend Yield: 3.03%
Payout Ratio: 40.34%
Dividend Per Share: 0.64 USD
Earnings Per Share: 0.24 USD
P/E Ratio: 81.25
Exchange: NMS
Sector: Healthcare
Industry: Health Information Services
Country: United States
Volume: 12200
Market Capitalization: 478.9 million
Average Dividend Frequency: 4
Years Paying Dividends: 23
DGR3: -14.29%
DGR5: 15.24%
DGR10: 24.94%